Filed: 8/14/2024ACC: 0001931118-24-000009
📋 What this filing means
SUPERSTRING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 39 equity positions with a total reported market value of $79.33M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
39
Positions
$79.33M
Total AUM (reported)
10.32M
Total Shares
Allocation by class
COM$42.79M53.9%
COM NEW$15.99M20.2%
SPONSORED ADS$7.05M8.9%
COMMON STOCK$4.87M6.1%
ADR$3.73M4.7%
SPONSORED ADR$1.78M2.2%
ORDINARY SHARES$1.43M1.8%
Portfolio Concentration
Top 3$23.53M29.7%
4–10$29.47M37.2%
11–25$20.57M25.9%
Rest$5.76M7.3%
Top 3 weight
29.7%
Top 10 weight
66.8%
Voting Authority Distribution
Total shares with voting rights: 10.32M
Sole
Full voting authority
10.32M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole39
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings39
Rows:
CYTOKINETICS INC
SOLEShares187.63K
TypeSH
Market value$10.17M
12.81%
Sole
187.63K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares154.66K
TypeSH
Market value$6.85M
8.64%
Sole
154.66K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares956.54K
TypeSH
Market value$6.51M
8.21%
Sole
956.54K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares219.84K
TypeSH
Market value$5.57M
7.02%
Sole
219.84K
Shared
0.00
None
0.00
89BIO INC
SOLEShares680.40K
TypeSH
Market value$5.45M
6.87%
Sole
680.40K
Shared
0.00
None
0.00
NKARTA INC
SOLEShares876K
TypeSH
Market value$5.18M
6.53%
Sole
876K
Shared
0.00
None
0.00
ZAI LAB LTD
SOLEShares215.18K
TypeSH
Market value$3.73M
4.70%
Sole
215.18K
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares74.29K
TypeSH
Market value$3.39M
4.28%
Sole
74.29K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares59.13K
TypeSH
Market value$3.26M
4.11%
Sole
59.13K
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS IN
SOLEShares111.13K
TypeSH
Market value$2.89M
3.64%
Sole
111.13K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares56.47K
TypeSH
Market value$2.56M
3.22%
Sole
56.47K
Shared
0.00
None
0.00
BEIGENE LTD
SOLEShares12.51K
TypeSH
Market value$1.78M
2.25%
Sole
12.51K
Shared
0.00
None
0.00
FATE THERAPEUTICS INC
SOLEShares497.36K
TypeSH
Market value$1.63M
2.06%
Sole
497.36K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS INC
SOLEShares689.91K
TypeSH
Market value$1.61M
2.03%
Sole
689.91K
Shared
0.00
None
0.00
PYXIS ONCOLOGY INC
SOLEShares484.44K
TypeSH
Market value$1.60M
2.02%
Sole
484.44K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares36.93K
TypeSH
Market value$1.45M
1.83%
Sole
36.93K
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC
SOLEShares1.15M
TypeSH
Market value$1.40M
1.77%
Sole
1.15M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
SOLEShares64.21K
TypeSH
Market value$1.23M
1.55%
Sole
64.21K
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares95.23K
TypeSH
Market value$1.22M
1.54%
Sole
95.23K
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares66.89K
TypeSH
Market value$1.15M
1.44%
Sole
66.89K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares45.57K
TypeSH
Market value$1.07M
1.35%
Sole
45.57K
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares139.90K
TypeSH
Market value$1.05M
1.32%
Sole
139.90K
Shared
0.00
None
0.00
TANGO THERAPEUTICS INC
SOLEShares115.57K
TypeSH
Market value$991.6K
1.25%
Sole
115.57K
Shared
0.00
None
0.00
ALLAKOS INC
SOLEShares940.58K
TypeSH
Market value$940.6K
1.19%
Sole
940.58K
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares87.64K
TypeSH
Market value$873.8K
1.10%
Sole
87.64K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYTOKINETICS INCSOLE | COM NEW | 187.63K | SH | $10.17M 12.81% | 187.63K | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 154.66K | SH | $6.85M 8.64% | 154.66K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 956.54K | SH | $6.51M 8.21% | 956.54K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 219.84K | SH | $5.57M 7.02% | 219.84K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 680.40K | SH | $5.45M 6.87% | 680.40K | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 876K | SH | $5.18M 6.53% | 876K | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 215.18K | SH | $3.73M 4.70% | 215.18K | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 74.29K | SH | $3.39M 4.28% | 74.29K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 59.13K | SH | $3.26M 4.11% | 59.13K | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INSOLE | COM | 111.13K | SH | $2.89M 3.64% | 111.13K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 56.47K | SH | $2.56M 3.22% | 56.47K | 0.00 | 0.00 |
BEIGENE LTDSOLE | SPONSORED ADR | 12.51K | SH | $1.78M 2.25% | 12.51K | 0.00 | 0.00 |
FATE THERAPEUTICS INCSOLE | COM | 497.36K | SH | $1.63M 2.06% | 497.36K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 689.91K | SH | $1.61M 2.03% | 689.91K | 0.00 | 0.00 |
PYXIS ONCOLOGY INCSOLE | COMMON STOCK | 484.44K | SH | $1.60M 2.02% | 484.44K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 36.93K | SH | $1.45M 1.83% | 36.93K | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INCSOLE | COM | 1.15M | SH | $1.40M 1.77% | 1.15M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYSOLE | ORDINARY SHARES | 64.21K | SH | $1.23M 1.55% | 64.21K | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COM | 95.23K | SH | $1.22M 1.54% | 95.23K | 0.00 | 0.00 |
NOVOCURE LTDSOLE | ORD SHS | 66.89K | SH | $1.15M 1.44% | 66.89K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 45.57K | SH | $1.07M 1.35% | 45.57K | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 139.90K | SH | $1.05M 1.32% | 139.90K | 0.00 | 0.00 |
TANGO THERAPEUTICS INCSOLE | COM | 115.57K | SH | $991.6K 1.25% | 115.57K | 0.00 | 0.00 |
ALLAKOS INCSOLE | COM | 940.58K | SH | $940.6K 1.19% | 940.58K | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 87.64K | SH | $873.8K 1.10% | 87.64K | 0.00 | 0.00 |
Page 1 of 2